Thomas Lycan
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Otorhinolaryngology top 10%
- Head and Neck Cancer Studies
Papers in
- Oncology 36
- Cancer Immunotherapy and Biomarkers 15
- Lung Cancer Research Studies 10
- Peptidase Inhibition and Analysis 4
-
- Brain Metastases and Treatment 10
- Lung Cancer Treatments and Mutations 9
- Lung Cancer Diagnosis and Treatment 5
- Co-authors
- Jimmy Ruiz (26 shared papers)W. Jeffrey Petty (22 shared papers)Tamjeed Ahmed (14 shared papers)Ümit Topaloĝlu (12 shared papers)Michael D. Chan (16 shared papers)Lawrence J. Cheskin (2 shared papers)Lisa Davis (2 shared papers)Michael Farris (13 shared papers)
- Journals
- Journal of Clinical Oncology (8 papers)International Journal of Radiation Oncology*Biology*Physics (7 papers)Cancers (6 papers)Journal of Thoracic Oncology (3 papers)JCO Oncology Practice (2 papers)
- Partner nations
- United States
In The Last Decade
Thomas Lycan
63 papers receiving 705 citations
Peers
Comparison fields: 5 of 78
- Oncology 243
- Otorhinolaryngology 38
- Pulmonary and Respiratory Medicine 152
- Cancer Research 62
- Pharmacy 14
Countries citing papers authored by Thomas Lycan
This map shows the geographic impact of Thomas Lycan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Lycan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Lycan more than expected).
Fields of papers citing papers by Thomas Lycan
This network shows the impact of papers produced by Thomas Lycan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Lycan. The network helps show where Thomas Lycan may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Lycan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 79 | |
| 2 | 2008 | 77 | |
| 3 | 2016 | 52 | |
| 4 | 2020 | 47 | |
| 5 | 2018 | 43 | |
| 6 | 2019 | 36 | |
| 7 | 2007 | 31 | |
| 8 | 2020 | 28 | |
| 9 | 2022 | 27 | |
| 10 | 2019 | 26 | |
| 11 | 2021 | 26 | |
| 12 | 2019 | 23 | |
| 13 | 2021 | 22 | |
| 14 | 2021 | 21 | |
| 15 | 2020 | 16 | |
| 16 | 2023 | 14 | |
| 17 | 2022 | 12 | |
| 18 | 2020 | 12 | |
| 19 | 2017 | 12 | |
| 20 | 2023 | 11 |
About Thomas Lycan
Thomas Lycan is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Otorhinolaryngology and Epidemiology, having authored 71 papers that have together received 722 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (15 papers), Lung Cancer Research Studies (10 papers), Brain Metastases and Treatment (10 papers), Lung Cancer Treatments and Mutations (9 papers), Head and Neck Cancer Studies (8 papers), Cancer Genomics and Diagnostics (5 papers), Lung Cancer Diagnosis and Treatment (5 papers) and Peptidase Inhibition and Analysis (4 papers). The work is most often cited by research in Oncology (243 citations), Otorhinolaryngology (38 citations), Pulmonary and Respiratory Medicine (152 citations), Cancer Research (62 citations) and Pharmacy (14 citations). Thomas Lycan has collaborated with scholars based in United States. Frequent co-authors include Jimmy Ruiz, W. Jeffrey Petty, Tamjeed Ahmed, Ümit Topaloĝlu, Michael D. Chan, Lawrence J. Cheskin, Lisa Davis, Michael Farris, Beverly J. Levine and Stefan C. Grant. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics, Cancers, Journal of Thoracic Oncology and JCO Oncology Practice.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.